Martin Köbel Selected Research

Martin Köbel Research Topics

Disease

81	Neoplasms (Cancer) 11/2023 - 03/2002
73	Carcinoma (Carcinomatosis) 11/2023 - 03/2002
23	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 01/2008
22	Endometrial Neoplasms (Endometrial Cancer) 06/2023 - 09/2008
20	Endometrioid Carcinoma 01/2022 - 04/2006
10	Ovarian Epithelial Carcinoma 11/2023 - 02/2010
8	Adenocarcinoma 01/2022 - 01/2003
6	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2006
6	Breast Neoplasms (Breast Cancer) 01/2021 - 06/2003
4	Endometriosis 01/2023 - 05/2017
4	Mucinous Adenocarcinoma (Mucinous Carcinoma) 11/2019 - 12/2009
3	Turcot syndrome 11/2023 - 01/2020
3	Disease Progression 01/2023 - 07/2014
3	Sarcoma (Soft Tissue Sarcoma) 05/2021 - 08/2018
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020 - 03/2013
3	Ascites 05/2012 - 03/2002
2	Carcinogenesis 02/2020 - 08/2008
2	Residual Neoplasm 01/2020 - 04/2006
2	Wilms Tumor (Wilm's Tumor) 01/2011 - 01/2009
1	Neuroendocrine Carcinoma 07/2022
1	Chromosomal Instability (Chromosome Stability) 01/2022
1	Ectrodactyly, Ectodermal Dysplasia, and Cleft Lip-Palate Syndrome 3 03/2021
1	Leiomyosarcoma 01/2021
1	Endometrial Stromal Sarcoma 01/2021

Drug/Important Bio-Agent (IBA)

31	Proteins (Proteins, Gene)FDA Link 11/2023 - 03/2002
30	Biomarkers (Surrogate Marker)IBA 11/2023 - 11/2007
10	Estrogen ReceptorsIBA 06/2023 - 06/2003
9	Sucrose (Saccharose)IBA 01/2023 - 03/2016
9	PlatinumIBA 11/2022 - 05/2012
9	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2009
7	Exonucleases (3' 5' Exonuclease)IBA 01/2020 - 07/2014
7	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 10/2009
6	Messenger RNA (mRNA)IBA 01/2023 - 03/2002
6	ParaffinIBA 01/2023 - 04/2006
6	Hormones (Hormone)IBA 06/2022 - 08/2013
6	AntibodiesIBA 01/2022 - 03/2012
5	MucinsIBA 01/2022 - 10/2011
5	Eosine Yellowish-(YS) (Eosin)IBA 07/2020 - 04/2015
4	Formaldehyde (Formol)FDA Link 01/2023 - 01/2013
4	RNA (Ribonucleic Acid)IBA 11/2022 - 04/2013
4	CytokinesIBA 01/2021 - 05/2003
4	Hematoxylin (Haematoxylon)IBA 04/2018 - 04/2015
3	Oral ContraceptivesIBA 01/2023 - 01/2009
3	ChromatinIBA 01/2022 - 01/2018
3	AntigensIBA 11/2020 - 01/2008
3	Estrogens (Estrogen)FDA Link 01/2020 - 06/2016
3	Carrier Proteins (Binding Protein)IBA 01/2019 - 03/2009
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2004 - 06/2003
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2004 - 03/2002
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2023 - 09/2005
2	ProteomeIBA 12/2022 - 01/2019
2	Phosphotransferases (Kinase)IBA 06/2022 - 01/2021
2	taxaneIBA 04/2022 - 01/2021
2	Cadherins (E-Cadherin)IBA 05/2021 - 07/2011
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 12/2009
2	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 01/2020
2	Coloring Agents (Dyes)IBA 01/2021 - 07/2020
2	Indicators and Reagents (Reagents)IBA 11/2020 - 08/2008
2	podocalyxinIBA 11/2020 - 03/2012
2	EnzymesIBA 11/2020 - 03/2002
2	VimentinIBA 11/2019 - 11/2015
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 02/2010
2	Fibronectins (Fibronectin)IBA 03/2012 - 01/2003
2	Hepatocyte Nuclear FactorsIBA 01/2011 - 01/2009
2	Insulin-Like PeptidesIBA 07/2010 - 03/2009
2	Granzymes (Granzyme)IBA 07/2009 - 01/2008
2	ezrinIBA 04/2006 - 04/2006
2	TenascinIBA 01/2005 - 01/2003
2	Protein Isoforms (Isoforms)IBA 11/2003 - 06/2003
2	ProstaglandinsIBA 06/2003 - 03/2002
1	Neurofibromin 1 (Neurofibromin)IBA 11/2023
1	ORALIT (ORS)IBA 01/2023
1	CyclinsIBA 01/2023
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2023
1	GSK-J4IBA 01/2023
1	purineIBA 12/2022
1	LipidsIBA 12/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2022
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 06/2022
1	SilverIBA 03/2022
1	Letrozole (Femara)FDA LinkGeneric 01/2022
1	Keratin-7 (Cytokeratin 7)IBA 05/2021
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 05/2021
1	TropomyosinIBA 01/2021
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2021
1	Immune Checkpoint ProteinsIBA 01/2021
1	AndrogensIBA 01/2021
1	DNA Polymerase IIIBA 01/2021
1	Testosterone (Sustanon)FDA Link 01/2021
1	ChemokinesIBA 01/2021

Therapy/Procedure

32	Therapeutics 01/2023 - 05/2003
18	Drug Therapy (Chemotherapy) 01/2023 - 08/2008
8	Neoadjuvant Therapy 04/2022 - 07/2011
4	Adjuvant Chemotherapy 01/2021 - 03/2009
3	Immunotherapy 11/2020 - 01/2017
3	Chemoradiotherapy 01/2020 - 03/2013
3	Tubal Sterilization (Tubal Ligation) 05/2017 - 01/2009
2	Precision Medicine 03/2022 - 11/2015
2	Radiotherapy 01/2022 - 01/2021
1	Mastectomy (Mammectomy) 01/2022